Clatterbridge was the first cancer research centre in the UK to give an injection of the Transgene experimental immunotherapy ...

The Phase I Trial data will be submitted to regulatory agencies for review for advancing the vaccine into a Phase II efficacy ...

Phase III trials that provide the pivotal ... the most common reason for premature discontinuation of randomized clinical trials, for reasons including over-optimism in recruitment and/or too ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Longboard Pharmaceuticals has commenced the Phase III DEEp OCEAN Study of its investigational oral drug bexicaserin for ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...

Investigators from UB’s CTSI were among those from several institutions who were recently awarded a two-year, $2.1 million grant from NCATS.

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all ...

The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...

Mavorixafor was generally well tolerated as a monotherapy and in combination with G-CSF, with no drug-related serious adverse ...